🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Dear Sir/Madam, We would like to invite you to participate in this clinical...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2025-03-01
Trial ID
NCT06741020
Treatments Being Tested
In this study, Adebrelimab combined with NALIRIFOX conversion therapy was p...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-06-05
Trial ID
NCT06475326
Treatments Being Tested
This project is a prospective, multi-center, multi-cohort exploratory clini...
Status
Recruiting
Location
China Pharmaceutical University Affiliated Nanjing Tianyinshan Hospital
Start Date
2025-05-22
Trial ID
NCT06893887
This is a Phase Ib study that will evaluate the Safety, Tolerability , Phar...
Status
Not Yet Recruiting
Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2025-05-30
Trial ID
NCT06963502
For patients with advanced liver cancer who have progressed after first-lin...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-04-30
Trial ID
NCT06375317
Treatments Being Tested
Pancreatic cancer is a highly malignant digestive system tumor with a very ...
Status
Recruiting
Location
Ningbo Medical Center Lihuili Hospital
Start Date
2025-03-25
Trial ID
NCT07542002
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Adabrel...
Status
Recruiting
Location
Gansu Province Cancer Hospital
Start Date
2025-01-03
Trial ID
NCT06737913
his is a single-arm, phase II clinical study evaluating the efficacy and sa...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-10
Trial ID
NCT07543783
This trial is conducted in patients with unresectable locally advanced esop...
Status
Recruiting
Location
Tianjin Cancer Hospital
Start Date
2024-06-19
Trial ID
NCT06452602
This study is a prospective, randomized ，multicencter, phase II clinical tr...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2024-11-30
Trial ID
NCT06684158
Treatments Being Tested